170 related articles for article (PubMed ID: 31659584)
1. Clinical characteristics and long-term follow-up of seven cases of anti-GABABR encephalitis in patients of Han Chinese descent.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2020 Feb; 41(2):373-378. PubMed ID: 31659584
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and elevated ProGRP and positive oligoclonal bands of 13 Chinese cases with anti-GABABR encephalitis.
Wu H; Wang Y; Wei K; Qiao S; Liu L; Zhang R; Cao L; Wang S; Liu X
Int J Dev Neurosci; 2021 Oct; 81(6):492-501. PubMed ID: 33973258
[TBL] [Abstract][Full Text] [Related]
3. Encephalitis with antibodies against the GABA
Chen X; Liu F; Li JM; Xie XQ; Wang Q; Zhou D; Shang H
Neurol Res; 2017 Nov; 39(11):973-980. PubMed ID: 28974152
[TBL] [Abstract][Full Text] [Related]
4. SCLC and anti-GABABR encephalitis: A retrospective analysis of 60 cases in China.
Jiang C; Zhu M; Wei D; Duan H; Zhang Y; Feng X
Thorac Cancer; 2022 Mar; 13(6):804-810. PubMed ID: 35132785
[TBL] [Abstract][Full Text] [Related]
5. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review.
Si Z; Wang A; Liu J; Zhang Z; Hu K
Neurol Sci; 2019 Apr; 40(4):769-777. PubMed ID: 30671737
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and prognosis of anti-GABABR encephalitis: A single-center experience.
Li Q; Zhang X; Zeng T; Yang B; Duan J; Tang Y
Medicine (Baltimore); 2023 Feb; 102(7):e32956. PubMed ID: 36800611
[TBL] [Abstract][Full Text] [Related]
7. The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy.
Cui J; Bu H; He J; Zhao Z; Han W; Gao R; Li X; Li Q; Guo X; Zou Y
Int J Neurosci; 2018 Jul; 128(7):627-633. PubMed ID: 29166136
[TBL] [Abstract][Full Text] [Related]
8. Isolated seizures are a common early feature of paraneoplastic anti-GABA
Maureille A; Fenouil T; Joubert B; Picard G; Rogemond V; Pinto AL; Thomas L; Ducray F; Quadrio I; Psimaras D; Berzero G; Antoine JC; Desestret V; Honnorat J
J Neurol; 2019 Jan; 266(1):195-206. PubMed ID: 30460450
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognostic analysis of anti-gamma-aminobutyric acid-B (GABA-B) receptor encephalitis in Northeast China.
Zhang X; Lang Y; Sun L; Zhang W; Lin W; Cui L
BMC Neurol; 2020 Jan; 20(1):1. PubMed ID: 31900128
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Anti-SOX1 and Anti-GABA
Qin W; Wang X; Yang J; Hu W
Clin Interv Aging; 2020; 15():171-175. PubMed ID: 32103919
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and prognosis of anti-γ-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China.
Feng X; Zhang Y; Gao Y; Zhang J; Yu S; Lv J; Zu Y; Wang L; Wang X
Front Neurol; 2022; 13():949843. PubMed ID: 36188394
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic limbic encephalitis associated with lung cancer.
Shen K; Xu Y; Guan H; Zhong W; Chen M; Zhao J; Li L; Wang M
Sci Rep; 2018 May; 8(1):6792. PubMed ID: 29717222
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune encephalitis positive for both anti-γ-aminobutyric acid B receptor and anticollapsin response-mediator protein 5 antibodies: A case report.
Xia J; Yin X; Zhu M; Cao J; Song X
Medicine (Baltimore); 2018 Jan; 97(3):e9574. PubMed ID: 29504979
[TBL] [Abstract][Full Text] [Related]
16. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.
Höftberger R; Titulaer MJ; Sabater L; Dome B; Rózsás A; Hegedus B; Hoda MA; Laszlo V; Ankersmit HJ; Harms L; Boyero S; de Felipe A; Saiz A; Dalmau J; Graus F
Neurology; 2013 Oct; 81(17):1500-6. PubMed ID: 24068784
[TBL] [Abstract][Full Text] [Related]
17. A Prognostic Analysis of the Outcomes in Patients With Anti-γ-Aminobutyric Acid B Receptor Encephalitis.
Chen W; Wang Y; Guo X; Gao L; Huang Z; Lin Y; Xue Q; Liu G; Zhang Y; Su Y
Front Immunol; 2022; 13():847494. PubMed ID: 35515002
[TBL] [Abstract][Full Text] [Related]
18. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.
van Coevorden-Hameete MH; de Bruijn MAAM; de Graaff E; Bastiaansen DAEM; Schreurs MWJ; Demmers JAA; Ramberger M; Hulsenboom ESP; Nagtzaam MMP; Boukhrissi S; Veldink JH; Verschuuren JJGM; Hoogenraad CC; Sillevis Smitt PAE; Titulaer MJ
Brain; 2019 Jun; 142(6):1631-1643. PubMed ID: 31009048
[TBL] [Abstract][Full Text] [Related]
19. The long-term outcome of neuropsychological function is favorable in patients with non-malignancy related anti-GABA
Ji C; Wu D; Chen Z; Wang K
BMC Neurol; 2021 Feb; 21(1):87. PubMed ID: 33622267
[TBL] [Abstract][Full Text] [Related]
20. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
